Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care Unit

作者
Andrew S. Allegretti,Paul Endres,Tyler Parris,Sophia J. Zhao,Megan F. May,Mary H. Sylvia-Reardon,Nicole Bezreh,Roberta Culbert-Costley,Lillian Ananian,Russel Joseph Roberts,Natasha D. Lopez,David M. Charytan,NINA E. TOLKOFF-RUBIN
出处
期刊:American Journal of Nephrology [Karger Publishers]
卷期号:51 (4): 318-326 被引量:20
标识
DOI:10.1159/000506412
摘要

BACKGROUND: Continuous renal replacement therapy (CRRT) is commonly employed in the intensive care unit (ICU), though there are no guidelines around the transition between CRRT and intermittent hemodialysis (iHD). Accelerated venovenous hemofiltration (AVVH) is a modality utilizing higher hemofiltration rates (4-5 L/h) with shorter session durations (8-10 h) to "accelerate" the clearance and volume removal that normally is spread out over a 24-h period in CRRT. We examined AVVH as a transition therapy between CRRT and iHD, with the aim of decreasing time on CRRT and providing a more graduated transition for hemodynamically unstable patients requiring RRT. METHODS: Retrospective cohort study describing the clinical outcomes and quality initiative experience of the integration of AVVH into the CRRT program at an academic tertiary care center. Outcomes of interest included mortality, ICU length of stay and readmission rates, and technical characteristics of treatments. RESULTS: In total, 97 patients received a total of 298 AVVH treatments (3.1 ± 3.3 treatments per patient). Totally, 271/298 (91%) treatments were completed successfully. During an average treatment time of 9.5 ± 1.6 h with 4.2 ± 0.5 L/h -replacement fluid rate, urea reduction ratio was 23 ± 26% per 10-h treatment, and net ultrafiltration volume was 2.4 ± 1.3 L/treatment. Inpatient mortality was 32%, mean total hospital length of stay was 54 ± 47 days. Sixty-four out of 97 (66%) patients recovered renal function by discharge. Among those who transferred out of the ICU, 7/62 (11%) patients required readmission to the ICU after developing hypotension on iHD. CONCLUSION: AVVH can serve as a transition therapy between CRRT and iHD in the ICU and has the potential to decrease total time on CRRT, improve patient mobility, and sustain low ICU readmission rates. Future study is needed to analyze the implications on resource use and cost of this modality.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
FYSYYC完成签到 ,获得积分10
刚刚
飞行员完成签到,获得积分10
1秒前
shilly发布了新的文献求助10
1秒前
吃土的牛马完成签到,获得积分10
1秒前
1秒前
LXD123完成签到,获得积分10
1秒前
wanci的应助被科研通管家采纳,获得10
1秒前
fanligang完成签到,获得积分10
1秒前
无极微光的应助被科研通管家采纳,获得20
1秒前
击剑男孩完成签到,获得积分10
1秒前
情怀的应助被科研通管家采纳,获得10
1秒前
Jasper的应助被科研通管家采纳,获得10
2秒前
852的应助被科研通管家采纳,获得10
2秒前
爆米花的应助被科研通管家采纳,获得10
2秒前
梦尔斯泰的应助被科研通管家采纳,获得10
2秒前
星辰大海的应助被科研通管家采纳,获得10
2秒前
5709xx的应助被科研通管家采纳,获得50
2秒前
Owen的应助被科研通管家采纳,获得10
2秒前
杰杰杰杰完成签到,获得积分10
2秒前
molihuakai的应助被科研通管家采纳,获得10
2秒前
人间打气筒完成签到,获得积分10
3秒前
chen完成签到,获得积分10
3秒前
3秒前
3秒前
3秒前
3秒前
3秒前
Lucas的应助被赵舒坦采纳,获得10
3秒前
深情安青的应助被时尚的海瑶采纳,获得10
3秒前
田様的应助被含糊的水卉采纳,获得10
4秒前
Hq完成签到 ,获得积分10
4秒前
4秒前
chy发布了新的文献求助10
4秒前
4秒前
机智的白卉的应助被安朵采纳,获得10
5秒前
zhao发布了新的文献求助10
5秒前
田様的应助被俊逸傲柏采纳,获得10
5秒前
5秒前
5秒前
大气代灵完成签到,获得积分10
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8152354
求助须知:如何正确求助?哪些是违规求助? 9549023
关于积分的说明 21690364
捐赠科研通 7740603
什么是DOI,文献DOI怎么找? 3425157
关于科研通互助平台的介绍 2550379
邀请新用户注册赠送积分活动 2468675